MARK G FOLETTA Insider Trading $BIOC BIOCEPT INC

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for MARK G FOLETTA.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of MARK G FOLETTA. MARK G FOLETTA is Senior VP, Finance & CFO in AMYLIN PHARMACEUTICALS INC ($AMLN) and Sr VP Finance & CFO in AMYLIN PHARMACEUTICALS INC ($AMLN) and SVP Chief Financial Officer in AMYLIN PHARMACEUTICALS INC ($AMLN) and SVP, Chief Financial Officer in AMYLIN PHARMACEUTICALS INC ($AMLN) and VP & Chief Financial Officer in AMYLIN PHARMACEUTICALS INC ($AMLN) and VP Finance & CFO in AMYLIN PHARMACEUTICALS INC ($AMLN) and Director in AMN HEALTHCARE SERVICES INC ($AHS) and Director in DEXCOM INC ($DXCM) and Director in ENANTA PHARMACEUTICALS INC ($ENTA) and Interim CFO in BIOCEPT INC ($BIOC) and EVP & Chief Financial Officer in Tocagen Inc ($TOCA) and Director in Regulus Therapeutics Inc. ($RGLS).

MARK G FOLETTA in BIOCEPT INC

Trading Symbol: BIOC
Industry: SERVICES-MEDICAL LABORATORIES [8071]
Position of MARK G FOLETTA: Interim CFO
Holdings: 0 shares
Current Value: $0
Latest Transaction: Sep 02 2015
$BIOC Market Capitalization: $29.57M
$BIOC Previous Close: $1.57

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of MARK G FOLETTA in BIOCEPT INC

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, AHS, AMLN, BIOC, DXCM, ENTA, TOCA, RGLS

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Sep 02 2015	BIOC	BIOCEPT INC	FOLETTA MARK G	Interim CFO	Option Exercise	A	2.01	50,000	100,500	50,000

Page: 1